Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (vol 8, 586, 2017)

被引：0
|
作者：
Guerzoni, Simona [1 ]
Pellesi, Lanfranco [1 ]
Baraldi, Carlo [1 ]
Cainazzo, Michela Maria [1 ]
Negro, Andrea [2 ]
Martelletti, Paolo [2 ]
Pini, Luigi Alberto [1 ,3 ]
机构：
[1] Univ Modena & Reggio Emilia, Policlin Hosp, Dept Diagnost Med Clin & Publ Hlth, Headache & Drug Abuse Res Ctr, Modena, Italy
[2] Sapienza Univ, St Andrea Hosp, Dept Clin & Mol Med, Reg Referral Headache Ctr, Rome, Italy
[3] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Dept Biomed Metab & Neural Sci, Modena, Italy
来源：
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
关键词：
chronic migraine; OnabotulinumtoxinA; long-term treatment; quality of life; tolerance; headache; medication overuse headache;
D O I：
10.3389/fneur.2018.00641
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 10 条
  • [1] Long-term Treatment Benifits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
    Guerzoni, Simona
    Pellesi, Lanfranco
    Baraldi, Carlo
    Cainazzo, Michela Maria
    Negro, Andrea
    Martelletti, Paolo
    Pini, Luigi Alberto
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [2] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Michail Vikelis
    Andreas A. Argyriou
    Emmanouil V. Dermitzakis
    Konstantinos C. Spingos
    Nikolaos Makris
    Evangelia Kararizou
    The Journal of Headache and Pain, 2018, 19
  • [3] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Vikelis, Michail
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Spingos, Konstantinos C.
    Makris, Nikolaos
    Kararizou, Evangelia
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [4] Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headache
    Blumenfeld, Andrew
    Kudrow, David
    Mcallister, Peter
    Boserup, Line Pickering
    Hirman, Joe
    Cady, Roger
    HEADACHE, 2024, 64 (07): : 738 - 749
  • [5] Long-term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil, V
    Vlachos, George S.
    Vikelis, Michail
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (06): : 676 - 683
  • [6] Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
    Tepper, Stewart J.
    Lipton, Richard B.
    Silberstein, Stephen D.
    Kudrow, David
    Ashina, Messoud
    Reuter, Uwe
    Dodick, David W.
    Wang, Andrea
    Cheng, Sunfa
    Klatt, Jan
    Mikol, Daniel D.
    HEADACHE, 2023, 63 (06): : 730 - 742
  • [7] Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy
    Antonio Santoro
    Massimiliano Copetti
    Anna M. Miscio
    Maurizio A. Leone
    Andrea Fontana
    Neurological Sciences, 2020, 41 : 1809 - 1820
  • [8] Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy
    Santoro, Antonio
    Copetti, Massimiliano
    Miscio, Anna M.
    Leone, Maurizio A.
    Fontana, Andrea
    NEUROLOGICAL SCIENCES, 2020, 41 (07) : 1809 - 1820
  • [9] Efficacy and Safety of OnabotulinumtoxinA Therapy are Sustained Over 4 Years of Treatment in Patients With Neurogenic Detrusor Overactivity: Final Results of a Long-Term Extension Study
    Kennelly, Michael
    Dmochowski, Roger
    Schulte-Baukloh, Heinrich
    Ethans, Karen
    Del Popolo, Giulio
    Moore, Courtenay
    Jenkins, Brenda
    Guard, Steven
    Zheng, Yan
    Karsenty, Gilles
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (02) : 368 - 375
  • [10] A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache
    Grazzi, Licia
    Raggi, Alberto
    Guastafierro, Erika
    Passavanti, Marco
    Marcassoli, Alessia
    Montisano, Danilo Antonio
    D'Amico, Domenico
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
1